Study results indicate that mutation strength may shape both tumor–immune system interactions and immunotherapy response.

Circulating tumor DNA may be an effective biomarker for stratifying patients with small cell lung cancer who would benefit from more stringent follow-ups and clinical trial participation.Patients who ...

Researchers have created the first complete map showing how hundreds of mutations in a key cancer gene affect tumor growth.

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers like lung ...